Format

Send to

Choose Destination
See comment in PubMed Commons below
Mol Cancer Res. 2014 Sep;12(9):1292-302. doi: 10.1158/1541-7786.MCR-14-0255-T. Epub 2014 May 21.

MIF antagonist (CPSI-1306) protects against UVB-induced squamous cell carcinoma.

Author information

1
Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, Ohio.
2
Department of Molecular Carcinogenesis, Science Park, The University of Texas MD Anderson Cancer Center, Smithville, Texas.
3
Center for Biostatistics, The Ohio State University Wexner Medical Center, Columbus, Ohio.
4
Cytokine PharmaSciences, King of Prussia, Pennsylvania.
5
Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, Ohio. oberyszyn.1@osu.edu.

Abstract

Macrophage migration inhibitory factor (MIF) is a homotrimeric proinflammatory cytokine implicated in chronic inflammatory diseases and malignancies, including cutaneous squamous cell carcinomas (SCC). To determine whether MIF inhibition could reduce UVB light-induced inflammation and squamous carcinogenesis, a small-molecule MIF inhibitor (CPSI-1306) was utilized that disrupts homotrimerization. To examine the effect of CPSI-1306 on acute UVB-induced skin changes, Skh-1 hairless mice were systemically treated with CPSI-1306 for 5 days before UVB exposure. In addition to decreasing skin thickness and myeloperoxidase (MPO) activity, CPSI-1306 pretreatment increased keratinocyte apoptosis and p53 expression, decreased proliferation and phosphohistone variant H2AX (γ-H2AX), and enhanced repair of cyclobutane pyrimidine dimers. To examine the effect of CPSI-1306 on squamous carcinogenesis, mice were exposed to UVB for 10 weeks, followed by CPSI-1306 treatment for 8 weeks. CPSI-1306 dramatically decreased the density of UVB-associated p53 foci in non-tumor-bearing skin while simultaneously decreasing the epidermal Ki67 proliferation index. In addition to slowing the rate of tumor development, CPSI-1306 decreased the average tumor burden per mouse. Although CPSI-1306-treated mice developed only papillomas, nearly a third of papillomas in vehicle-treated mice progressed to microinvasive SCC. Thus, MIF inhibition is a promising strategy for prevention of the deleterious cutaneous effects of acute and chronic UVB exposure.

IMPLICATIONS:

Macrophage migration inhibitory factor is a viable target for the prevention of UVB-induced cutaneous SSCs.

PMID:
24850900
PMCID:
PMC4284200
DOI:
10.1158/1541-7786.MCR-14-0255-T
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Support Center